Scarica l'app Stockscreener
1.06
6.00%
0.06
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart
Grain Spreads: Profit Taking Theme - Barchart
Stocks Rally On Dovish PCE Inflation Report - Barchart
Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart
Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart
Is W.R. Berkley Stock Outperforming The Dow? - Barchart
PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart
Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart
Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart
Stocks Regain Footing On Dovish PCE Inflation Report - Barchart
Enterprise Products Stock Rises 25% YTD: Should You Buy Now Or Avoid It? - Barchart
Knightscope K7 Alpha Testing Underway And 2024 Recap - Barchart
Take-Two (NASDAQ:TTWO): Strongest Q3 Results From The Video Gaming Group - Barchart
Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown - Barchart
Q3 Video Conferencing Earnings: Five9 (NASDAQ:FIVN) Earns Top Marks - Barchart
Rude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
Crude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart
Federal Reserve's Preferred Inflation Gauge Shows Price Pressures Eased Last Month - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - AccessWire
MIRA Pharmaceuticals Submits FDA Application for Breakthrough Pain Treatment Targeting $3.1B Market - StockTitan
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment - Benzinga
AI’s Next Big Winners: 3 Small-Cap Stocks To Watch In 2025 - Barchart
1 'Strong Buy' Penny Stock With 259% Upside Potential - Barchart
4 Big Drug Stocks That May Continue To Outperform In 2025 - Barchart
Will SentinelOne Stock Break Out In 2025? - Barchart
Should You Buy Bitcoin Below $115,000? - Barchart
Should You Buy Palantir Before Dec. 23? - Barchart
Meet the Dow Jones' Top Performing Stock This Year. It's Climbed 2,300% Over the Past 5 Years, and Its Biggest Catalyst May Be Just Ahead. - Barchart
Wall Street's 3 Favorite Auto Stocks Worth Buying For 2025 - Barchart
This AI Stock Could Get Supercharged In 2025 Thanks To Apple - Barchart
Below-Average Rainfall In Brazil Supports Coffee Prices - Barchart
Is Super Micro Stock A Buy, Sell, Or Hold Amidst Nasdaq Troubles? - Barchart
MIRA Pharmaceuticals (NASDAQ:MIRA) Validates Ketamir-2’s Safety Profile with No Adverse Findings, Paving the Way for IND Submission by Year-End - Defense World
MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End - Brazosport Facts
MIRA Pharmaceuticals' Novel Ketamine Drug Aces Preclinical Safety Tests, Phase I Trials Set for 2025 - StockTitan
EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain - Yahoo Finance
Stocks Settle Lower Ahead Of US Inflation News - Barchart
Marvell Technology (NASDAQ:MRVL) Delivers Strong Q3 Numbers, Stock Soars - Barchart
Altimmune Stock Up More Than 25% In A Month: Here's Why - Barchart
A Look Back at Large-format Grocery & General Merchandise Retailer Stocks’ Q3 Earnings: Walmart (NYSE:WMT) Vs The Rest Of The Pack - Barchart
1 Standout Stock To Buy At A Discount After Strong Earnings - Barchart
Walmart becomes the latestand biggestcompany to pull back back on diversity, equity and inclusion initiatives - Barchart
NVDA Stock Looks Cheap To Value Buyers Based On Its Huge FCF Margins - Barchart
Stocks Rally On The Prospects Of Trump’s Business-Friendly Policies - Barchart
Mira Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia
Mira Pharmaceuticals appoints new board member - Investing.com India
MIRA Pharmaceuticals Appoints New Board Member and Chairman - TipRanks
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site - AccessWire
Buy Nvidia's Stock For Another Leg Higher As Q3 Earnings Approach? - Barchart
2 Cybersecurity Stocks To Buy And Hold For 2025 - Barchart
Why Amazon (AMZN) Stock Is Down Today - Barchart
Neurogene Stock Plummets 44%: Is All Hope Lost For This Biotech?" - Barchart
Heron Therapeutics: Q3 Earnings Snapshot - Barchart
Post-Election Manufacturing Boom: 3 Stocks Analysts Are Eyeing - Barchart
3 Top EV Stocks To Buy In November - Barchart
Meet 3 Supercharged Growth Stocks That Could Profit From a Trump Presidency, According to Certain Wall Street Analysts - Barchart
Rigetti Set To Report Q3 Earnings: Buy, Sell Or Hold The Stock? - Barchart
2 Top Dividend-Growth Finance Stocks To Buy In November - Barchart
Mira Pharmaceuticals (MIRA) Price Target Increased by 37.58% to 23.15 - MSN
Zillow (NASDAQ:ZG) Delivers Strong Q3 Numbers, Stock Jumps 14.5% - Barchart
Top Stock Picks For Week Of November 4, 2024 - Barchart
Where Will C3.ai Stock Be In 5 Years? - Barchart
What Did The October Close Of The S&P 500 Mean? - Barchart
Microsoft Stock Down Over 5% Amid Concerns Over Outlook, Retail Sees Weakness As ‘Once In A Lifetime Opportunity’ - Barchart
MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain - Mugglehead
MIRA Pharmaceuticals Shares Surge 40% After Ketamir-2 Excels in Pain Management Trials - Yahoo Finance
1.83%
1.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):